Tasosartan

Drug Profile

Tasosartan

Alternative Names: ANA 756; Verdia; WAY 126756; WAY ANA 756

Latest Information Update: 26 Nov 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Wyeth
  • Class Antihypertensives; Pyridones; Pyrimidines; Small molecules; Tetrazoles; Vasodilators
  • Mechanism of Action Angiotensin type 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Heart failure; Hypertension

Most Recent Events

  • 26 Nov 1999 Discontinued-III for Heart failure in World (Unknown route)
  • 26 Nov 1999 Discontinued-III for Hypertension in World (PO)
  • 26 Nov 1999 Discontinued-preregistration for Hypertension in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top